Synthesis and preliminary pharmacological results on new naphthalene derivatives as 5-HT4 receptor ligands

European Journal of Medicinal Chemistry

Volumn 35, Issue 7-8, 2000, Pages 699-706

  Diouf, Ousmane ^a   Depreux, Patrick ^a   Chavatte, Philippe ^a   Poupaert, Jacques Henri ^b  

^a Inst Chim Pharmaceut Albert L   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

5 HT receptor; Serotonin

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 1 [(1 (2 (METHYLSULFONAMIDO)ETHYL)PIPERIDIN 4 YL)METHYLOXYCARBONYL]NAPHTHALENE HYDROCHLORIDE; 3 ETHYL 2,3 DIHYDRO 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 4 AMINO 5 CHLORO 2 METHOXYBENZOIC ACID 2 (DIETHYLAMINO)ETHYL ESTER; 8 AMINO 7 CHLORO 1,4 BENZODIOXAN 5 CARBOXYLIC ACID 1 BUTYL 4 PIPERIDINYLMETHYL ESTER; CISAPRIDE; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE; RS 56532; SEROTONIN; SEROTONIN 4 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TROPISETRON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GUINEA PIG; HIPPOCAMPUS; MOLECULAR MODEL; NONHUMAN; PHYSICAL CHEMISTRY; RADIOASSAY; RECEPTOR AFFINITY;

EID: 0033928622     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(00)00163-X     Document Type: Article

References (44)

1. Bockaert J., Fozard J.R., Dumuis A., Clarke D.E. Trends Pharmacol. Sci. 13:1992;141-145.
2. Eglen R.M., Swank S.R., Walsh L.K., Whiting R.L. Br. J. Pharmacol. 101:1990;513-520.
3. Costall B., Naylor R.J. Int. Clin. Psychopharm. 8:1993;11-18.
4. Kaumann A.J., Sanders L., Brown A.M., Murray K.J., Brown M.J. Br. J. Pharmacol. 100:1990;879-885.
5. Consolo S., Arnaboldi S., Giorgi S., Russi G., Ladinsky H. Neuroreport. 5:1994;1230-1232.
6. Boddeke H.W.G., Kalkman H.O. Br. J. Pharmacol. 101:1990;281-284.
7. Reynolds G.P., Mason S.L., Meldrum A., Keczer S., Parnes H., Eglen R.M., Wong E.H.F. Br. J. Pharmacol. 114:1995;993-998.
8. Gerald C., Adham N., Kao H.T., Olse M., Laz T.M., Schechter L.E., Bard J.A., Vaysse P.J., Hartig P.R., Branchek T.A., Weinshank R.L. EMBO J. 14:1995;2806-2815.
9. Claeysen S., Faye P., Sebben M., Lemaire S., Bockaert J., Dumuis A. Neuropharmacol. Neurotoxicol. 8:1997;3189-3196.
10. Bockaert J., Sebben M. Mol. Pharmacol. 37:1990;408-411.
11. Kaumann A.J. Naunyn Schmiedeberg's Arch. Pharmacol. 342:1990;619-622.
12. Baxter G.S., Craig D.A., Clarke D.E. Naunyn Schmiedeberg's Arch. Pharmacol. 343:1991;439-446.
13. Hegde S.S., Eglen R.M. FASEB J. 10:1996;1398-1407.
14. Dumuis A., Bouhelal R., Sebgben M., Cory R., Bockaert J. Mol. Pharmacol. 34:1988;880-887.
15. Bockaert J., Fagni L., Sebben M., Dumuis A. Fozard J.R, Sexena P.R. Serotonin: Molecular Biology, Receptors and Functional Effects, Birkhauser Verlag, Basel. 1991;220-231.
16. Graul A., Silvestre J., Castaner J. Drugs Future 24. 24:1999;38-44.
17. Itoh K., Kanzaki K., Ikebe T., Kuroita T., Tomozane H., Sonda S., Sato N., Haga K., Kawakita T. Eur. J. Med. Chem. 34:1999;329-341.
18. Yoshikawa T., Yoshida N., Mine Y., Hosoki K. Jpn. J. Pharmacol. 77:1998;53-59.
19. Tapia I., Alonso-Cires L., Lopez-Tucanda P.L., Mosquera R., Labeaga L., Innerarity A., Orjales A. J. Med. Chem. 42:1999;2870-2880.
20. Buchheit K.H., Gamse R.P., Pfannküche H.J. Naunyn Schmiedeberg's Arch. Pharmacol. 345:1991;387-393.
21. Yang D., Soulier J.L., Sicsic S., Mathé-Allainmat M., Brémont B., Croci T., Cardamone R., Aureggi G., Langlois M. J. Med. Chem. 40:1997;608-621.
22. Gaster L.M., King F.D. Med. Res. Rev. 17:1197;163-214.
23. Wardle K.A., Ellis L.M., Gaster L.M., King F.D., Sanger G.J. Br. J. Pharmacol. 110:1993;1593-1599.
24. Gale J.D., Groosmann C.J., Whitehead J.W.F., Oxford A.W., Bunce K.T., Humphrey P.P.A. Br. J. Pharmacol. 111:1994;332-338.
25. Grossman C.J., Kilpatrick G.J., Bunce K.T. Br. J. Pharmacol. 109:1993;618-624.
26. Wardle K.A., Bingham S., Ellis E.S., Gaster L.M., Rushant B., Smith M.I., Sanger G.J. Br. J. Pharmacol. 118:1996;665-670.
27. Monge A., Pena M., Palop J.A., Caldero J.M., Roca J., Garcia E., Romero G., Del Rio J., Lasheras. J. Med. Chem. 37:1994;1320-1325.
28. Özkan A., Yildiz I., Yüksel L., Apak H., Celkan T. Jpn. J. Clin. Oncol. 29:1999;92-95.
29. Clarke D.E., Craig D.A., Fozard J.R. Trends Pharmacol. Sci. 10:1989;385-386.
30. Hodge C.W., Niehus J.S., Samson H.H. Psychopharmacol. 119:1995;186-192.
31. Schaus J.M., Thompson D.C., Bloomquist W.E., Susemichel A.D., Calligaro D.O., Cohen M.L. J. Med. Chem. 41:1998;1943-1955.
32. Wong E.H., Reynolds G.P., Bonhaus D.W., Hsu S., Eglen R.M. Behav. Brain Res. 73:1996;249-252.
33. Ansanay H., Sebben M., Bockaert J., Dumuis A. Eur. J. Pharmacol. 298:1996;165-174.
34. Ford A.P.D.W., Clarke D.E. Med. Res. Rev. 13:1993;633-662.
35. Chaput Y., Areneda R.C., Andrade R. Eur. J. Pharmacol. 182:1990;441-456.
36. Costall B., Domeney A.M., Gerrard P.A., Kelly M.E., Naylor R.J. J. Pharm. Pharmacol. 40:1998;302-305.
37. Diouf O., Depreux P., Lesieur I., Renard P., Adam G., Fr. Appl. Pat. (1993) 93/12527.
38. Yous S., Depreux P., Renard P. Arch. Pharmacol. 326:1993;119-120.
39. Yous S., Andrieux J., Howell H.E., Morgan P.J., Renard P., Pfeiffer B., Lesieur D., Guardiola-Lemaître B. J. Med. Chem. 35:1992;1484-1485.
40. Abdellaoui H., Depreux P., Lesieur D., Pfeiffer B., Bontempelli P. Synth. Comm. 25:1995;1303-1311.
41. Kaumann A.J. Br. J. Pharmacol. 110:1993;879-885.
42. Schmidt A.W., Peroutka S.J. Mol. Pharmacol. 36:1989;505-511.
43. SYBYL 6.2, Tripos Associates, Inc., St.Louis, MO.
44. Grossman C.J., Kilpatrick G.J., Bunce K.T. Br. J. Pharmacol. 109:1993;618-624.